Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic

Basit Öğe Kaydı
dc.contributor.authorToruner, Murat
dc.contributor.authorKalkan, Ismail Hakki
dc.contributor.authorAkyuz, Filiz
dc.contributor.authorTezel, Ahmet
dc.contributor.authorCelik, Aykut Ferhat
dc.date.accessioned2024-06-12T11:03:52Z
dc.date.available2024-06-12T11:03:52Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThe COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2, has resulted in high mortality and morbidity worldwide and is still a growing problem. Inflammatory bowel disease (IBD) is a chronic inflammatory disease for which a substantial number of patients are treated with immunosuppressive medications, either occasionally or long-term. Despite the accumulating evidence, there is still a lack of knowledge about the impact of COVID-19 on IBD patients, especially those who are under immunosuppressive treatment. Moreover, following the emergence of several COVID vaccines, there are concerns regarding vaccine effectiveness and possible side effects in such patients. In this context, we tried to briefly summarize the accumulating evidence and recommendations for the management of IBD in the context of the COVID-19 pandemic.en_US
dc.identifier.doi10.5152/tjg.2021.280721
dc.identifier.endpage492en_US
dc.identifier.issn2148-5607
dc.identifier.issue6en_US
dc.identifier.pmid34405814en_US
dc.identifier.scopus2-s2.0-85114407808en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage488en_US
dc.identifier.urihttps://doi.org/10.5152/tjg.2021.280721
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21801
dc.identifier.volume32en_US
dc.identifier.wosWOS:000687054600001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal Of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectInflammatory Bowel Diseasesen_US
dc.subjectCrohn's Diseaseen_US
dc.subjectUlcerative Colitisen_US
dc.subjectCOVID-19 Pandemicen_US
dc.subjectImmune-Responseen_US
dc.subjectOpportunistic Infectionsen_US
dc.subjectClinical Characteristicsen_US
dc.subjectCoronavirus Diseaseen_US
dc.subjectVaccineen_US
dc.titleTurkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemicen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu